Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis

Atherosclerosis

Volumn 207, Issue 2, 2009, Pages 585-590

  Reis, Jared P ^a   von Mühlen, Denise ^b   Michos, Erin D ^c   Miller III, Edgar R ^a   Appel, Lawrence J ^a   Araneta, Maria R ^b   Barrett Connor, Elizabeth ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cardiovascular diseases; Parathyroid hormone; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; PARATHYROID HORMONE; VITAMIN D;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; B SCAN; BLOOD SAMPLING; CAROTID ARTERY DISEASE; CAROTID ATHEROSCLEROSIS; CLINICAL EXAMINATION; COHORT ANALYSIS; COMMUNITY LIVING; CONTROLLED STUDY; DIABETES MELLITUS; EXERCISE; FEMALE; HUMAN; HYPERTENSION; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SMOKING; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WAIST HIP RATIO;

EID: 70450225533     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.05.030     Document Type: Article

References (45)

1. Forman J.P., Giovannucci E., Holmes M.D., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49 (2007) 1063-1069
2. Knekt P., Laaksonen M., Mattila C., et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 19 (2008) 666-671
3. Melamed M.L., Muntner P., Michos E.D., et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 28 (2008) 1179-1185
4. Giovannucci E., Liu Y., Hollis B.W., and Rimm E.B. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168 (2008) 1174-1180
5. Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117 (2008) 503-511
6. Melamed M.L., Michos E.D., Post W., and Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168 (2008) 1629-1637
7. Dobnig H., Pilz S., Scharnagl H., et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168 (2008) 1340-1349
8. Andersson P., Rydberg E., and Willenheimer R. Primary hyperparathyroidism and heart disease-a review. Eur Heart J 25 (2004) 1776-1787
9. Hedback G., and Oden A. Increased risk of death from primary hyperparathyroidism-an update. Eur J Clin Invest 28 (1998) 271-276
10. Kamycheva E., Sundsfjord J., and Jorde R. Serum parathyroid hormone levels predict coronary heart disease: The Tromso Study. Eur J Cardiovasc Prev Rehabil 11 (2004) 69-74
11. Arad Y., Spadaro L.A., Roth M., et al. Serum concentration of calcium, 1,25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography study. Coron Artery Dis 9 (1998) 513-518
12. Watson K.E., Abrolat M.L., Malone L.L., et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96 (1997) 1755-1760
13. Targher G., Bertolini L., Padovani R., et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 65 (2006) 593-597
14. Criqui M.H., Barrett-Connor E., and Austin M. Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol 108 (1978) 367-372
15. Hollingshead A. Hollingshead two-factor index of social position (1991), Sage, Newbury Park, CA
16. Criqui M.H., Cowan L.D., Tyroler H.A., et al. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the lipid research clinics follow-up study. Am J Epidemiol 126 (1987) 629-637
17. Hypertension Detection and Follow-up Program Cooperative Group. The Hypertension Detection and Follow-up Program. Prev Med 5 (1976) 207-215
18. Chen T.C., Turner A.K., and Holick M.F. A method for the determination of the circulating concentration of vitamin D. J Nutr Biochem 1 (1990) 272-276
19. Chen T.C., Turner A.K., and Holick M.F. A method for the determination of the circulating concentration of 1,25-dihydroxyvitamin D. J Nutr Biochem 1 (1990) 320-327
20. Lipid research clinics program, manual of laboratory operations. Lipid and lipoprotein analysis. US Department of Health, E.a.W.p. (1974), US Government Printing Office, Washington, DC
21. Levey A.S., Coresh J., Greene T., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
22. Cardiovascular Health Study Collaborative Research Group, O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., and Wolfson Jr. S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340 (1999) 14-22
23. Choi H.S., Kim S.H., Rhee Y., Cho M.A., Lee E.J., and Lim S.K. Serum parathyroid hormone is associated with carotid intima-media thickness in postmenopausal women. Int J Clin Pract 62 (2008) 1352-1357
24. Doherty T.M., Tang W., Dascalos S., et al. Ethnic origin and serum levels of 1alpha, 25-dihydroxyvitamin D3 are independent predictors of coronary calcium mass measured by electron-beam computed tomography. Circulation 96 (1997) 1477-1481
25. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79 (2004) 362-371
26. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., and Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115 (2007) 459-467
27. Carallo C., Irace C., Pujia A., et al. Evaluation of common carotid hemodynamic forces. Relations with wall thickening. Hypertension 34 (1999) 217-221
28. Gnasso A., Carallo C., Irace C., et al. Association between intima-media thickness and wall shear stress in common carotid arteries in healthy male subjects. Circulation 94 (1996) 3257-3262
29. Cardiovascular Health Study Collaborative Research Group, O'Leary D.H., Polak J.F., Kronmal R.A., et al. Thickening of the carotid wall. A marker for atherosclerosis in the elderly?. Stroke 27 (1996) 224-231
30. Usdin T.B., Bonner T.I., Harta G., and Mezey E. Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat. Endocrinology 137 (1996) 4285-4297
31. Carthy E.P., Yamashita W., Hsu A., and Ooi B.S. 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 13 (1989) 954-959
32. Shioi A., Katagi M., Okuno Y., et al. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res 91 (2002) 9-16
33. Rigby W.F., Denome S., and Fanger M.W. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 79 (1987) 1659-1664
34. Bachschmid M.M., and van der Loo B. A new "sunshine" in the vasculature?. Circulation 111 (2005) 1571-1573
35. Somjen D., Weisman Y., Kohen F., et al. 25-Hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111 (2005) 1666-1671
36. Zehnder D., Bland R., Chana R.S., et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 13 (2002) 621-629
37. Wakasugi M., Noguchi T., Inoue M., et al. Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins 42 (1991) 127-136
38. Zittermann A., Schleithoff S.S., and Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 94 (2005) 483-492
39. Norman P.E., and Powell J.T. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler Thromb Vasc Biol 25 (2005) 39-46
40. Zittermann A., and Koerfer R. Protective and toxic effects of vitamin D on vascular calcification: clinical implications. Mol Aspects Med 29 (2008) 423-432
41. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., and Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110 (2002) 229-238
42. Xiang W., Kong J., Chen S., et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 288 (2005) E125-132
43. Kasuga H., Hosogane N., Matsuoka K., et al. Characterization of transgenic rats constitutively expressing vitamin D-24-hydroxylase gene. Biochem Biophys Res Commun 297 (2002) 1332-1338
44. Binkley N., Krueger D., Cowgill C.S., et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 89 (2004) 3152-3157
45. Lips P., Chapuy M.C., Dawson-Hughes B., Pols H.A., and Holick M.F. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 9 (1999) 394-397